All Day Pain Relief

Product NDC
59726-256
11-digit product format
597260256
Labeler code
59726
Product ID
59726-256_eef8b012-dd93-4d27-9b3d-7be965d7c8da
Type
HUMAN OTC DRUG
Nonproprietary name
Naproxen Sodium
Dosage form
TABLET
Route
ORAL
Labeler
P & L Development, LLC
Application
ANDA091353
Marketing category
ANDA
Marketing start
2014-03-28
Marketing end
0000-00-00
Substance
NAPROXEN SODIUM
Active strength
220 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct59726-256DDiscontinued by firm2026-07-31
excluded packagepackage59726-25659726-256-15DDiscontinued by firm2026-07-31

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A091353-001NAPROXEN SODIUMNAPROXEN SODIUM220MGTABLET / ORAL2011-09-20

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rapidol NaproxenNAPROXEN SODIUMPharmadel LLCc94c4b6e-a48b-cee5-e053-2995a90a49ac2026-03-20WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMGranules USA, Inc.8cb8030c-b281-315c-e053-2a95a90a36f02025-12-22WarningsExact identifier
NaproxenNAPROXENSafeway, Incf2a273f8-d623-dc2f-e053-2995a90a0c022025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMSafeway, Incf2a297c2-3898-5e47-e053-2995a90ab3cc2025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMTARGET CORPORATIONfdb87abd-3176-dd62-e053-6394a90a6fcc2025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMCVS1042b202-e8ee-1839-e063-6294a90ac90b2025-12-19WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMCVS10429d07-de96-5542-e063-6294a90a73712025-12-19WarningsExact identifier
Dr Simi All Day Pain ReliefNAPROXEN SODIUMFarmacias De Similares TX LLC3c6d4bb5-eb6f-944b-e063-6294a90ae8de2025-08-15WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMBi-Mart6d5cecc9-5095-477b-bfc7-45b6e7e689f02025-03-01WarningsExact identifier
NAPROXEN SODIUMNAPROXEN SODIUMSPIRIT PHARMACEUTICALS,LLCa690dc39-95f2-4853-a291-05d7dc9a15512024-12-30WarningsExact identifier
Pain ReliefNAPROXEN SODIUMGobrands, Incae4bfa8c-ae41-4fcd-b584-872cc4d376832024-12-20WarningsExact identifier
PROXEN NP 660NAPROXEN SODIUMOPMX LLC09990b2f-202e-b4df-e063-6394a90a055b2023-12-27WarningsExact identifier
Naproxen SodiumNAPROXEN SODIUMGranules India Ltd95ba1722-60ed-4a83-9f26-50c4de8cf1802023-02-06WarningsExact identifier
All Day Pain ReliefNAPROXEN SODIUM TABLETS, 220 MGHealthLife of USA LLC7b0cb91e-5465-40ef-9f82-919f7d984f172017-06-01WarningsExact identifier

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

warnings

Warnings Allergy a lert: Naproxen sodium may cause severe skin reactions. Symptoms may include: hives facial swelling asthma (wheezing) shock skin reddening rash blisters. If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning : This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you: are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen or others) have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery Ask a doctor before use if the stomach bleeding warning applies to you you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic you have problems or serious side effects from taking pain relievers or fever reducers Ask a doctor or pharmacist before use if you are under a doctor’s care for any serious condition taking aspirin for heart attack or stroke, because naproxen may decrease this benefit of aspirin taking any other drugs When using this product take with food or milk if stomach upset occurs Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing slurred speech leg swelling weakness in one part or side of body pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days you have difficulty swallowing it feels like the pill is stuck in your throat redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or...

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NAPROXEN SODIUMACTIVE INGREDIENT9TN87S3A3CALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
NAPROXENACTIVE MOIETY57Y76R9ATQALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933ALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
POVIDONE K30INACTIVE INGREDIENTU725QWY32XALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
SODIUM STARCH GLYCOLATE TYPE A CORNINACTIVE INGREDIENTAG9B65PV6BALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPALL DAY PAIN RELIEF (NAPROXEN SODIUM) TABLET [P AND L DEVELOPMENT OF NEW YORK CORPORATION (READYINCASE)]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
59726-256-15597260256151 BOTTLE, PLASTIC in 1 BOX (59726-256-15) > 15 TABLET in 1 BOTTLE, PLASTIC2014-03-280000-00-00NoNoCurrent